Cargando…

The Toll–Like Receptor 2/6 Agonist, FSL–1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome

Risks of radiation exposure from nuclear incidents and cancer radiotherapy are undeniable realities. These dangers urgently compel the development of agents for ameliorating radiation–induced injuries. Biologic pathways mediated by myeloid differentiation primary response gene 88 (MyD88), the common...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurkjian, Cathryn J., Guo, Hao, Montgomery, Nathan D., Cheng, Ning, Yuan, Hong, Merrill, Joseph R., Sempowski, Gregory D., Brickey, W. June, Ting, Jenny P.-Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725477/ https://www.ncbi.nlm.nih.gov/pubmed/29230065 http://dx.doi.org/10.1038/s41598-017-17729-9

Ejemplares similares

Prevention and Mitigation of Acute Radiation Syndrome in Mice by Synthetic Lipopeptide Agonists of Toll-Like Receptor 2 (TLR2)
por: Shakhov, Alexander N., et al.
Publicado: (2012)

Human Amnion Epithelial Cells (AECs) Respond to the FSL-1 Lipopeptide by Engaging the NLRP7 Inflammasome
por: Lavergne, Marilyne, et al.
Publicado: (2020)

FSL-1, a bacterial-derived toll-like receptor 2/6 agonist, enhances resistance to experimental HSV-2 infection
por: Rose, William A, et al.
Publicado: (2009)

FSL-1, a Toll-like Receptor 2/6 Agonist, Induces Expression of Interleukin-1α in the Presence of 27-hydroxycholesterol
por: Heo, Weon, et al.
Publicado: (2014)

Multiple Signaling Molecules are Involved in Expression of CCL2 and IL-1β in Response to FSL-1, a Toll-Like Receptor 6 Agonist, in Macrophages
por: Won, Keunsoo, et al.
Publicado: (2012)

FSL‐MRS: An end‐to‐end spectroscopy analysis package
por: Clarke, William T., et al.
Publicado: (2020)

The Toll-Like Receptor 5 Agonist Entolimod Mitigates Lethal Acute Radiation Syndrome in Non-Human Primates
por: Krivokrysenko, Vadim I., et al.
Publicado: (2015)

Quantitative Comparison of SPM, FSL, and Brainsuite for Brain MR Image Segmentation
por: Kazemi, K, et al.
Publicado: (2014)

Intratumoural injection of the toll-like receptor-2/6 agonist ‘macrophage-activating lipopeptide-2’ in patients with pancreatic carcinoma: a phase I/II trial
por: Schmidt, J, et al.
Publicado: (2007)

Assessment of the Impact of a Toll-like Receptor 2 Agonist Synthetic Lipopeptide on Macrophage Susceptibility and Responses to African Swine Fever Virus Infection
por: Franzoni, Giulia, et al.
Publicado: (2022)

Altered explorative strategies and reactive coping style in the FSL rat model of depression
por: Magara, Salvatore, et al.
Publicado: (2015)

Comparison of accuracy between FSL’s FIRST and Freesurfer for caudate nucleus and putamen segmentation
por: Perlaki, Gabor, et al.
Publicado: (2017)

Toll-like receptor 2 activation depends on lipopeptide shedding by bacterial surfactants
por: Hanzelmann, Dennis, et al.
Publicado: (2016)

Fully automated open‐source lesion mapping of T2‐FLAIR images with FSL correlates with clinical disability in MS
por: Wetter, Nathan C., et al.
Publicado: (2016)

Reproducing FSL's fMRI data analysis via Nipype: Relevance, challenges, and solutions
por: Chen, Yibei, et al.
Publicado: (2022)

FSL-Kla: A few-shot learning-based multi-feature hybrid system for lactylation site prediction
por: Jiang, Peiran, et al.
Publicado: (2021)

Isolates of Salmonella typhimurium circumvent NLRP3 inflammasome recognition in macrophages during the chronic phase of infection
por: Cai, David, et al.
Publicado: (2021)

Non-dopaminergic Alterations in Depression-Like FSL Rats in Experimental Parkinsonism and L-DOPA Responses
por: Schintu, Nicoletta, et al.
Publicado: (2020)

Single nucleotide polymorphisms in toll-like receptor 6 are associated with altered lipopeptide- and mycobacteria-induced IL-6 secretion
por: Shehu Shey, Muki, et al.
Publicado: (2010)

Real-Time fMRI Pattern Decoding and Neurofeedback Using FRIEND: An FSL-Integrated BCI Toolbox
por: Sato, João R., et al.
Publicado: (2013)

PS133. The role of Toxoplasma gondii in depression and anxiety - gene-environment interactions in the FSL rat model
por: Bay-Richter, Cecilie, et al.
Publicado: (2016)

Exploring fMRI Results Space: 31 Variants of an fMRI Analysis in AFNI, FSL, and SPM
por: Pauli, Ruth, et al.
Publicado: (2016)

Complete Genome Sequence of a Serotype 7 Listeria monocytogenes Strain, FSL R9-0915
por: Peters, Tracey Lee, et al.
Publicado: (2021)

Mild-stretch mechanical ventilation upregulates toll-like receptor 2 and sensitizes the lung to bacterial lipopeptide
por: Charles, Pierre-Emmanuel, et al.
Publicado: (2011)

Lipopeptides for Vaccine Development
por: Hamley, Ian W.
Publicado: (2021)

Repeatability and reproducibility of FreeSurfer, FSL-SIENAX and SPM brain volumetric measurements and the effect of lesion filling in multiple sclerosis
por: Guo, Chunjie, et al.
Publicado: (2018)

Inhibition of mitochondrial complex I by the novel compound FSL0260 enhances high salinity-stress tolerance in Arabidopsis thaliana
por: Sako, Kaori, et al.
Publicado: (2020)

Anti-radiation damage effect of polyethylenimine as a toll-like receptor 5 targeted agonist
por: Hu, Zhiqiang, et al.
Publicado: (2013)

Targeting Toll-Like Receptor 2: Polarization of Porcine Macrophages by a Mycoplasma-Derived Pam2cys Lipopeptide
por: Franzoni, Giulia, et al.
Publicado: (2021)

H2-DMα(−/)− Mice Show the Importance of Major Histocompatibility Complex–Bound Peptide in Cardiac Allograft Rejection
por: Felix, Nathan J., et al.
Publicado: (2000)

Toll-Like Receptor 9 Agonists in Cancer
por: Karapetyan, Lilit, et al.
Publicado: (2020)

Efficacy of Distortion Correction on Diffusion Imaging: Comparison of FSL Eddy and Eddy_Correct Using 30 and 60 Directions Diffusion Encoding
por: Yamada, Haruyasu, et al.
Publicado: (2014)

Subcortical and hippocampal brain segmentation in 5‐year‐old children: Validation of FSL‐FIRST and FreeSurfer against manual segmentation
por: Lidauer, Kristian, et al.
Publicado: (2022)

Clinical evaluation of toll-like receptor-5 agonist for radiation-induced oral mucositis in beagle dogs
por: Ko, Jaeeun, et al.
Publicado: (2022)

A TLR9 agonist enhances the anti-tumor immunity of peptide and lipopeptide vaccines via different mechanisms
por: Song, Ying-Chyi, et al.
Publicado: (2015)

NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes
por: Freeman, Leslie, et al.
Publicado: (2017)

Toll-Like Receptor 9 Agonists for Cancer Therapy
por: Melisi, Davide, et al.
Publicado: (2014)

Toll-Like Receptor Agonists as Adjuvants for Allergen Immunotherapy
por: Kirtland, Max E., et al.
Publicado: (2020)

Bias of the Immune Response to Pneumocystis murina Does Not Alter the Ability of Neonatal Mice to Clear the Infection
por: Kurkjian, Cathryn, et al.
Publicado: (2021)

Applications and clinical trial landscape using Toll-like receptor agonists to reduce the toll of cancer
por: Rolfo, Christian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6d4hc8ntg9pubf7gkcc1tcuaqc